AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE BESYLATE; TELMISARTAN
25 registrations across 2 African markets— 25 active
Markets with AMLODIPINE BESYLATE; TELMISARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMTEL TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | May 2031 |
| AMTEL TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | May 2031 |
| AMTEL TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | May 2031 |
| AMTEL TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | May 2031 |
| AMLOCAL PLUS 5/80 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | N2SA LIMITED | active | Apr 2031 |
| AMLOCAL PLUS 5/40 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | N2SA LIMITED | active | Apr 2031 |
| TELAM 40/10 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| TELAM 40/5 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| TELAM 80/10 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| TELAM 80;5 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| ACTAPRESS DUO 5/80 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Oct 2030 |
| ACTAPRESS DUO 10/80 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Oct 2030 |
| ACTAPRESS DUO 10/40 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Oct 2030 |
| ACTAPRESS DUO 5/40 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Oct 2030 |
| CP-AMLODIPINE PLUS 40/10 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Aug 2030 |
| CP-AMOLIDIPINE PLUS 80/5 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Aug 2030 |
| MIZART PLUS 40/10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED [OTL] | active | Mar 2030 |
| MIZART PLUS 40/5 TABLET; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Mar 2030 |
| MIZART PLUS 80/10 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Mar 2030 |
| MIZART PLUS 80/5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Mar 2030 |
| AMLODIPINE TELMISARTAN TABLETS (each tablet contains Amlodipine Besylate/Telmisartan 80mg/10mg) | 🇬🇭Ghana | — | active | Aug 2028 |
| AMLODIPINE TELMISARTAN TABLETS (each tablet contains Amlodipine Besylate/Telmisartan 80mg/10mg) | 🇬🇭Ghana | — | active | Aug 2028 |
| AMLODIPINE TELMISARTAN TABLETS (each tablet contains Amlodipine Besylate/Telmisartan 40mg/10mg) | 🇬🇭Ghana | — | active | Aug 2028 |
| AMLODIPINE TELMISARTAN TABLETS (each tablet contains Amlodipine Besylate/Telmisartan 40mg/10mg) | 🇬🇭Ghana | — | active | Aug 2028 |
| INDIVAN AM TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | — |
AMLODIPINE BESYLATE; TELMISARTAN in Africa — Regulatory Overview
AMLODIPINE BESYLATE; TELMISARTAN is registered across 2 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Ghana. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 25 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.